Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Conditions
Chronic Hepatitis Delta
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Investigative Site, Anaheim, California, United States
University of Louisville, Clinical Trials Unit, Louisville, Kentucky, United States
University of Maryland, Institute of Human Virology, Clinical Research Unit, Baltimore, Maryland, United States
The New York-Presbyterian Hospital, New York, New York, United States
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, SC Gastroenterologia ed Epatologia, Milan, Italy
IMSP Spitalul Clinic de Boli Infectioase "Toma Ciorba", Chinsinau, Moldova
IMSP Spitalul Clinic de Boli Infectioase "Toma Ciorba", Chisinau, Moldova
PMSI Clinical Republican Hospital "Timofei Mosneaga", Chisinau, Moldova
Institutul National De Boli Infectioase Prof. Dr. Matei Bals, Bucharest, Romania
Fundatia Dr. Victor Babes, Bucharest, Romania
Infectious Diseases Institutul National De Boli Infectioase Prof. Matei Bals, Bucharest, Romania
Gastromedica S.R.L., Iași, Romania
Korea University Ansan Hospital, Ansan-si, South Korea
The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon-si, South Korea
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Study leads
Gilead Study Director
Study Director
Gilead Sciences